fig4
![Quantitative hepatitis B surface antigen in predicting recurrence of hepatitis B-related hepatocellular carcinoma after liver transplantation](https://image.oaes.cc/2af25a41-f32c-4695-8dec-a83b3410da79/2827.fig.4.png)
Figure 4. A: Cumulative incidence of hepatocellular carcinoma recurrence according to hs-HBsAg level at 3 months after liver transplantation; B: cumulative incidence of hepatocellular carcinoma recurrence according to hs-HBsAg level at 6 months after liver transplantation; C: cumulative incidence of hepatocellular carcinoma recurrence according to hs-HBsAg level at 1 month after liver transplantation